A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment

Allan I. Levey, Deqiang Qiu, Liping Zhao, William T. Hu, Duc M. Duong, Lenora Higginbotham, Eric B. Dammer, Nicholas T. Seyfried, Thomas S. Wingo, Chadwick M. Hales, Malú Gámez Tansey, David S. Goldstein, Anees Abrol, Vince D. Calhoun, Felicia C. Goldstein, Ihab Hajjar, Anne M. Fagan, Doug Galasko, Steven D. Edland, John HanfeltJames J. Lah, David Weinshenker

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment'. Together they form a unique fingerprint.

Medicine & Life Sciences